338 results on '"T, Borsos"'
Search Results
252. Isoelectric focusing of human and guinea-pig C2: polymorphism of guinea-pig C2.
253. Ontogeny of the first component of sheep complement.
254. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
255. ESTIMATION OF MOLECULAR SIZE OF COMPLEMENT COMPONENTS BY SEPHADEX CHROMATOGRAPHY.
256. Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cells.
257. CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.
258. Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.
259. Introduction: methodology for detection of antigens in preneoplastic and neoplastic tissues.
260. C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody.
261. Cytotoxic action of antiserum and complement: quantification with a colony inhibition method.
262. Serum gamma globulin and Trypanosoma cruzi agglutinin in embryonic, normal and germ-free chickens.
263. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4.
264. Quantitation of hemorrhagic lesions in the chick embryo produced by the Rous tumor virus.
265. Complement and Hemolysis.
266. ACTION OF THE FIRST COMPONENT OF COMPLEMENT. ACTIVITATION OF C'1 TO C'1A IN THE HEMOLYTIC SYSTEM.
267. Complement fixation: a modified procedure designed to eliminate anticomplementary and procomplementary effects.
268. Separation of components of guinea pig complement by chromatography.
269. Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.
270. Ultracentrifugation of the first component of complement: effects of ionic strength.
271. Detection of bound C3 by a new immunochemical methods.
272. The first component of complement in serum: evidence for a hitherto unrecognized factor in C1 necessary for internal activation.
273. DIFFERENCES IN SERUM COMPLEMENT ACTIVITY AMONG INBRED STRAINS OF MICE.
274. Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.
275. Tumor-specific antigens: detection by local transfer of delayed skin hypersensitivity.
276. Tumor-specific antigens detected by inhibition of macrophage migration.
277. Synthesis of the second component of guinea pig complement in vitro.
278. Detection of endotoxin in commercial L-asparaginase preparations by complement fixation and separation by chromatography.
279. Forssman antigen content of guinea pig hepatomas induced by diethylnitrosamine: a quantitative approach to the search for tumor-specific antibodies.
280. LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS.
281. Structural characteristics of hemolytic antibodies as determined by the effects of ionizing radiation.
282. Systemic transfer of tumor immunity: delayed hypersensitivity and suppression of tumor growth.
283. STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. II. RESOLUTION OF THE E TRANSFORMATION REACTION INTO MULTIPLE STEPS.
284. Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant.
285. Pathogenesis of Rous sarcoma virus in the chick embryo with particular reference to vascular lesions.
286. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. IV. Formation of EAC42 by treatment of C2 with trypsin in the presence of EAC4.
287. Lysis of tumor cells by antibody and complement. 1. Lack of correlation between antigen content and lytic susceptibility.
288. In vitro synthesis of the first component of complement by guinea pig small intestine.
289. Effect of C3 inactivator on bound C3 antigen.
290. Production of the second (C2) and fourth (C4) components of guinea pig complement by single peritoneal cells: evidence that one cell may produce both components.
291. EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS.
292. Cold-reacting antibodies: the enhancement of antibody fixation by the first component of complement (C'1a).
293. Synthesis of the first component of human complement in vitro.
294. Complement fixation on cell surfaces by 19S and 7S antibodies.
295. Action of a phospholipase C preparation on the first component of complement of guinea pig and human serum: lack of correlation with enzyme activity.
296. Tumor-specific antigen solubilized by hypertonic potassium chloride.
297. Mouse complement: influence of sex hormones on its activity.
298. Synthesis of the first component of guinea pig complement by columnar epithelial cells of the small intestine.
299. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. II. Clustering of effective C42 complexes at individual hemolytic sites.
300. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.